SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aurobindo Pharma gets USFDA’s nod for Donepezil Hydrochloride Tablets

01 Jun 2011 Evaluate

Aurobindo Pharma, the market leader in semi-synthetic penicillin drugs has received approval from the US Food & Drug Administration (USFDA) for its tentatively approved ANDA for Donepezil Hydrochloride Tablets 5mg and 10mg.

Donepezil Hydrochloride Tablets 5mg and 10mg is the generic equivalent to Aricept Tablets 5mg and 10mg of Eisai Medical Research Inc. Donepezil Hydrochloride Tablets are indicated for the treatment of mild, moderate, and severe dementia of the Alzheimer's type and fall under the central nervous system (CNS) therapeutic segment. The product will be launched soon which has a market size of approximately $2.5 billion for the twelve months ending September 2010 according to IMS.

The company now has a total of 136 ANDA approvals (106 Final approvals and 30 tentative approvals) from USFDA.

Aurobindo Pharma, headquartered at Hyderabad, India, manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company’s manufacturing facilities are approved by several leading regulatory agencies like US FDA, UK MHRA, WHO, Health Canada, MCC South Africa, ANVISA Brazil.

Aurobindo Pharma Share Price

1488.50 9.95 (0.67%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×